Effect of sibutramine on weight reduction and insulin resistance in women with polycystic ovary syndrome.
Neoklis A
NA
Georgopoulos
Ilias
I
Katsikis
Dimos
D
Florakis
Dimitrios
D
Panidis
Evanthia Diamanti
ED
Kandarakis
D001067:Appetite Depressants / Q000494:pharmacology / Q000627:therapeutic use*; D015992:Body Mass Index; D001835:Body Weight / Q000187:drug effects*; D003503:Cyclobutanes / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D009765:Obesity / Q000097:blood / Q000188:drug therapy*; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy*; D015431:Weight Loss / Q000187:drug effects*
D001067:Appetite Depressants; D003503:Cyclobutanes; C058254:sibutramine